ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA and Apremilast MRI Study in PsA

0 views
December 14, 2023

The above content is not sponsored by, nor part of, the American College of Rheumatology.

Comments 0
Login to view comments. Click here to Login